World's Best Scientists 2026 revealed!
Rowan T. Chlebowski

Rowan T. Chlebowski

D-Index & Metrics

Medicine

D-Index
119
Citations
80887
World Ranking
3811
National Ranking
2089

Rowan T. Chlebowski publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Rowan T. Chlebowski sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 665 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Rowan T. Chlebowski D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Rowan T. Chlebowski sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 119 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Rowan T. Chlebowski is a researcher affiliated with UCLA Medical Center in the United States. Their work primarily focuses on oncology and related medical fields, with a significant body of research addressing cancer risks, hormonal effects, and survivorship.

Chlebowski's research spans the main fields of Medicine and Biochemistry, Genetics and Molecular Biology, with notable subfields including Oncology, Genetics, Cancer Research, Public Health, Environmental and Occupational Health, and Endocrinology, Diabetes and Metabolism.

The scientist has contributed to numerous topics, such as:

  • Cancer Risks and Factors
  • Estrogen and related hormone effects
  • Global Cancer Incidence and Screening
  • Menopause: Health Impacts and Treatments
  • Cancer survivorship and care
  • Breast Cancer Treatment Studies
  • Nutritional Studies and Diet

Frequent publication venues for Rowan T. Chlebowski include:

  • Journal of Clinical Oncology
  • Cancer
  • Breast Cancer Research and Treatment
  • Cancer Research
  • UNC Libraries

Chlebowski often collaborates with the following coauthors:

  • Kathy Pan
  • Aaron K. Aragaki
  • JoAnn E. Manson
  • Aladdin H. Shadyab
  • Jean Wactawski-Wende

Among the recent papers published by Rowan T. Chlebowski are:

  • Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials (2020, JAMA)
  • Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized Trial (2020, Journal of Clinical Oncology)

Other relevant recent publications associated with the team, where Chlebowski is a known contributor or affiliated in research context, include:

  • ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe (2022, Annals of Oncology)
  • The Women's Health Initiative Randomized Trials and Clinical Practice (2024, JAMA)
  • Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women's Health Initiative (2020, Cancer)

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

    Garnet L. Anderson;Marian C. Limacher;Annlouise R. Assaf;Tamsen Bassford

  • Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women’s Health Initiative Randomized Trial

    Rowan T. Chlebowski;Susan L. Hendrix;Robert D. Langer;Marcia L. Stefanick

  • Calcium plus vitamin D supplementation and the risk of fractures.

    Rebecca D. Jackson;Andrea Z. LaCroix;Margery Gass;Robert B. Wallace

  • Design of the Women's Health Initiative clinical trial and observational study

    G. Anderson;S. Cummings;L. S. Freedman;C. Furberg

  • Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women's health initiative randomized trials

    Jo Ann E. Manson;Rowan T. Chlebowski;Marcia L. Stefanick;Aaron K. Aragaki

  • American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004

    Eric P. Winer;Clifford Hudis;Harold J. Burstein;Antonio C. Wolff

  • Low-fat dietary pattern and risk of cardiovascular disease : The women's health initiative randomized controlled dietary modification trial

    Barbara V. Howard;Barbara V. Howard;Linda Van Horn;Judith Hsia;JoAnn E. Manson

  • The decrease in breast-cancer incidence in 2003 in the United States

    Peter M. Ravdin;Kathleen A. Cronin;Nadia Howlader;Christine D. Berg

  • Calcium plus Vitamin D Supplementation and the Risk of Colorectal Cancer

    Jean Wactawski-Wende;Jane Morley Kotchen;Garnet L. Anderson;Annlouise R. Assaf;Annlouise R. Assaf

  • American Society of Clinical Oncology 2003 Update on the Role of Bisphosphonates and Bone Health Issues in Women With Breast Cancer

    Bruce E. Hillner;James N. Ingle;Rowan T. Chlebowski;Julie Gralow

  • Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. Early Breast Cancer Trialists' Collaborative Group.

    IC Henderson;H Mouridsen;O Abe;M Abeloff

  • Exemestane for Breast-Cancer Prevention in Postmenopausal Women

    Paul E. Goss;James N. Ingle;José E. Alés-Martínez;Angela M. Cheung

  • Low-Fat dietary pattern and risk of invasive breast cancer: The women's health initiative randomized controlled dietary modification trial

    Ross L. Prentice;Bette Caan;Rowan T. Chlebowski;Ruth Patterson

  • Dietary Fat Reduction and Breast Cancer Outcome: Interim Efficacy Results From the Women's Intervention Nutrition Study

    Rowan T. Chlebowski;George L. Blackburn;Cynthia A. Thomson;Daniel W. Nixon

  • Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

    Nasim Mavaddat;Kyriaki Michailidou;Kyriaki Michailidou;Joe Dennis;Michael Lush

  • Estrogen plus progestin and colorectal cancer in postmenopausal women.

    Rowan T. Chlebowski;Jean Wactawski-Wende;Cheryl Ritenbaugh;F. Allan Hubbell

  • Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States).

    Libby M. Morimoto;Emily White;Z. Chen;Rowan T. Chlebowski

  • Effects of Conjugated Equine Estrogens on Breast Cancer and Mammography Screening in Postmenopausal Women With Hysterectomy

    Marcia L. Stefanick;Garnet L. Anderson;Karen L. Margolis;Susan L. Hendrix

  • Weight Loss in Breast Cancer Patient Management

    Rowan T. Chlebowski;Erin Aiello;Anne McTiernan

Frequent Co-Authors

JoAnn E. Manson
JoAnn E. Manson Harvard Medical School
Marcia L. Stefanick
Marcia L. Stefanick Stanford University
Jean Wactawski-Wende
Jean Wactawski-Wende University at Buffalo, State University of New York
Ross L. Prentice
Ross L. Prentice Fred Hutchinson Cancer Research Center
Garnet L. Anderson
Garnet L. Anderson Fred Hutchinson Cancer Research Center
Thomas E. Rohan
Thomas E. Rohan Albert Einstein College of Medicine
Karen C. Johnson
Karen C. Johnson University of Tennessee Health Science Center
Cynthia A. Thomson
Cynthia A. Thomson University of Arizona
Bette J. Caan
Bette J. Caan Kaiser Permanente
Lewis H. Kuller
Lewis H. Kuller University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in medicine, there are several related online degrees and career pathways that offer flexibility and rewarding opportunities. For example, many students choose nursing as a stepping stone. Today, there are nursing schools that don't require teas test, making the admissions process smoother for prospective nurses.

For those interested in leadership within healthcare, pursuing a health care administration degree can open doors to management roles and non-clinical careers. If you are already a registered nurse with an associate's degree, there are streamlined asn to nurse practitioner programs that let you advance quickly to higher levels of patient care.

Additionally, nutrition is an essential part of patient wellness and preventative care. An online degree in nutrition can lead to a fulfilling career in dietary consulting, public health, or education.

Exploring these online options can help you build specialized skills, offer job flexibility, and broaden your impact in healthcare beyond traditional medical degrees.

Best Scientists Citing Rowan T. Chlebowski

Trending Scientists

Recently Published Articles